go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Adliance GmbH

Organization type
RDM medtech
Cluster
Medical Technology Cluster
Details

Everynear GmbH

Organization type
RDM medtech
Region
Lower Austria
Topic
hospital hardware
Details

Biegler GmbH

Organization type
RDM medtech
Region
Lower Austria
Details

Baxter Medical Products GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
biological-derived devices
single-use devices
resuable devices
Details

Contact



Contact: